首页> 外文期刊>Antimicrobial agents and chemotherapy. >Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.
【24h】

Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.

机译:embB密码子306处的突变是结核分枝杆菌中乙胺丁醇抗性的重要分子指标。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Ethambutol resistance in clinical Mycobacterium tuberculosis isolates is associated primarily with missense mutations in the embB gene. However, recent reports have described the presence of embB mutations, especially those at embB codon 306, in isolates susceptible to ethambutol. To clarify the role of embB mutations in ethambutol resistance, we sequenced the ethambutol resistance-determining region in spontaneous ethambutol-resistant mutants. In our study, 66% of spontaneous mutants contained a single point mutation in embB, with 55% of these occurring at embB 306. The MIC of ethambutol for spontaneous mutants was increased two- to eightfold relative to the pansusceptible M. tuberculosis strains from which the mutants were generated. To further characterize the role of embB 306 mutations, we directly introduced mutant alleles, embB(M306V) or embB(M306I), into pansusceptible M. tuberculosis strains and conversely reverted mutant alleles in spontaneous ethambutol-resistant mutants back to those of the wild type via allelic exchange using specialized linkage transduction. We determined that the MIC of ethambutol was reduced fourfold for three of the four spontaneous ethambutol-resistant embB 306 mutants when the mutant allele was replaced with the wild-type embB allele. The MIC for one of the spontaneous mutants genetically reverted to wild-type embB was reduced by only twofold. When the wild-type embB allele was converted to the mutant allele embB(M306V), the ethambutol MIC was increased fourfold, and when the allele was changed to M306I, the ethambutol MIC increased twofold. Our data indicate that embB 306 mutations are sufficient to confer ethambutol resistance, and detection of these mutations should be considered in the development of rapid molecular tests.
机译:临床结核分枝杆菌中乙胺丁醇的耐药性主要与embB基因的错义突变有关。然而,最近的报道描述了在对乙胺丁醇敏感的分离物中存在emB突变,特别是在emB密码子306处的emB突变。为了阐明embB突变在乙胺丁醇抗性中的作用,我们在自发的乙胺丁醇抗性突变体中对乙胺丁醇抗性确定区域进行了测序。在我们的研究中,66%的自发突变体在embB中包含一个单点突变,其中55%发生在embB306。乙胺丁醇对自发突变体的MIC相对于易感性结核分枝杆菌菌株增加了2到8倍。产生了突变体。为了进一步表征embB 306突变的作用,我们将突变等位基因embB(M306V)或embB(M306I)直接引入易感性结核分枝杆菌菌株中,然后将自发对乙胺丁醇抗性突变体中的突变等位基因反向还原为野生型通过使用专门的连锁转导的等位基因交换。我们确定,当用野生型embB等位基因取代突变体等位基因时,四个自发的对乙胺丁醇耐药的embB 306突变体中的三个突变体的乙胺丁醇的MIC降低了四倍。基因还原为野生型embB的自发突变体之一的MIC仅降低了两倍。当野生型embB等位基因转化为突变等位基因embB(M306V)时,乙胺丁醇MIC增加了4倍,当等位基因改变为M306I时,乙胺丁醇MIC增加了2倍。我们的数据表明embB 306突变足以赋予乙胺丁醇抗性,在快速分子测试的发展中应考虑检测这些突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号